nafamostat has been researched along with Foreign-Body Reaction in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Foreign-Body Reaction: Chronic inflammation and granuloma formation around irritating foreign bodies.
Excerpt | Relevance | Reference |
---|---|---|
"Nafamostat mesilate may suppress the blood-foreign surface reaction similar to biocompatible materials by blocking factor XIIa." | 2.68 | Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials. ( Hibi, M; Hiroura, M; Kawamura, M; Murakami, F; Murase, M; Ooshima, H; Tomita, Y; Usui, A; Yoshida, K, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Usui, A | 1 |
Hiroura, M | 1 |
Kawamura, M | 1 |
Hibi, M | 1 |
Yoshida, K | 1 |
Murakami, F | 1 |
Tomita, Y | 1 |
Ooshima, H | 1 |
Murase, M | 1 |
1 trial available for nafamostat and Foreign-Body Reaction
Article | Year |
---|---|
Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials.
Topics: Benzamidines; Biocompatible Materials; Blood Coagulation Factors; Bradykinin; Cardiopulmonary Bypass | 1996 |